Evidence map›Paper›PMID 36008344›Full record

ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2022

[Screening, domestication and identification of intestinal uric acid degrading bacteria in low uric acid population].

Tingting Tian, Wujin Chen, Meiting Liang, Mayina Kahaer, Rui Li, Yuping Sun

Open access · greenAbstract read
In one paragraph

Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tingting TianBasic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Wujin ChenMorphological Center, Basic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Meiting LiangBasic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Mayina KahaerDepartment of Microbiology, Basic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Rui LiDepartment of Microbiology, Basic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Yuping SunDepartment of Microbiology, Basic Medical College, Xinjiang Medical University, Urumqi 830000, P. R. China.
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the largest ecosystem of human body, intestinal microorganisms participate in the synthesis and metabolism of uric acid. Developing and utilizing intestinal bacteria to degrade uric acid might provide new ideas for the treatment of hyperuricemia. The fecal samples of people with low uric acid were inoculated into uric acid selective medium with the concentration of 1.5 mmol/L for preliminary screening, and the initially screened strains that may have degradation ability were domesticated by concentration gradient method, and the strains with high uric acid degradation rate were identified by 16S rRNA sequencing method. A strain of high-efficiency uric acid degrading bacteria was screened and domesticated from the feces of people with low uric acid. The degradation rate of uric acid could reach 50.2%. It was identified as

Indexed as

HyperuricemiaUric AcidBacteriaDomesticationEcosystemEscherichia coliHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16SUric AcidDomesticationLow uric acid populationScreenUric acid degradation rateUric acid degrading bacteria

Identifiers

PMID36008344
PMCPMC10957345
OpenAlexW4293866250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.